APO Research
Talk to an analyst

APO RESEARCH · REPORT

Covid-19 Serology Testing

Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.These tests can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodies to the virus.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.These tests can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodies to the virus.

Selected research

Market Analysis & Forecast

Global Covid-19 Serology Testing Market Analysis and Forecast 2026-2032

28 December 2025191 pages

Choose your research edition.

Industry ResearchCovid-19 Serology Testing Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Covid-19 Serology Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Covid-19 Serology Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Covid-19 Serology Testing Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Covid-19 Serology Testing Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.These tests can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodies to the virus.

North America is the largest consumption place, with a consumption market share nearly 35.21% in 2020. APAC is the second largest consumption place with the consumption market share of 32.43%.

Market competition is intense. Abbott, Guangzhou Wondfo Biotech, BioMedomics, Kantaro, Roche, etc. are the leaders of the industry. The top 5 companies occupied about half of the market in 2019.

Read the full market overview

Among the classification of Covid-19 Serology Testing, the proportion of Chemiluminescent Immunoassay in 2020 is about 73.45%.

Covid-19 Serology Testing is widely used for Hospitals and Third-party laboratory. The most proportion of Covid-19 Serology Testing is Hospitals, and the proportion in 2020 is 52.47%.

Report Includes

This report presents an overview of global market for Covid-19 Serology Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Covid-19 Serology Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Covid-19 Serology Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Covid-19 Serology Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Covid-19 Serology Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Covid-19 Serology Testing revenue, projected growth trends, production technology, application and end-user industry.

Covid-19 Serology Testing Segment by Company

Abbott

Guangzhou Wondfo Biotech

BioMedomics

Kantaro

Roche

Cellex

Innovita Biological Technology

Zhejiang Orient Gene Biotech

Ortho Clinical Diagnostics

Guangdong Hecin-Scientific

Dynamiker Biotechnology (Tianjin)

Chembio Diagnostics

Safecare Bio-Tech

Covid-19 Serology Testing Segment by Type

Rapid Diagnostic Test (RDT)

Chemiluminescent Immunoassay

Other

Covid-19 Serology Testing Segment by Application

Hospitals

Third-party laboratory

Covid-19 Serology Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Covid-19 Serology Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Covid-19 Serology Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Covid-19 Serology Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Covid-19 Serology Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Covid-19 Serology Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Covid-19 Serology Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Covid-19 Serology Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Rapid Diagnostic Test (RDT) Major Player Table 3. Chemiluminescent Immunoassay Major Player Table 4. Other Major Player Table 5. Global Covid-19 Serology Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Player Table 7. Third-party laboratory Major Player Table 8. Covid-19 Serology Testing Industry Trends Table 9. Covid-19 Serology Testing Industry Drivers Table 10. Covid-19 Serology Testing Industry Opportunities and Challenges Table 11. Covid-19 Serology Testing Industry Restraints Table 12. Global Covid-19 Serology Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Covid-19 Serology Testing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Covid-19 Serology Testing Market Share by Region (2021-2026) Table 15. Global Covid-19 Serology Testing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Covid-19 Serology Testing Market Share by Region (2027-2032) Table 17. Global Covid-19 Serology Testing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Covid-19 Serology Testing Revenue Market Share by Players (2021-2026) Table 19. Global Covid-19 Serology Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Covid-19 Serology Testing Key Players Headquarters & Area Served Table 21. Global Covid-19 Serology Testing Players, Product Type & Application Table 22. Global Covid-19 Serology Testing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Covid-19 Serology Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Covid-19 Serology Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Covid-19 Serology Testing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Covid-19 Serology Testing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Covid-19 Serology Testing Revenue Market Share by Type (2021-2026) Table 29. Global Covid-19 Serology Testing Revenue Market Share by Type (2027-2032) Table 30. Global Covid-19 Serology Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Covid-19 Serology Testing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Covid-19 Serology Testing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Covid-19 Serology Testing Revenue Market Share by Application (2021-2026) Table 34. Global Covid-19 Serology Testing Revenue Market Share by Application (2027-2032) Table 35. Abbott Company Information Table 36. Abbott Business Overview Table 37. Abbott Covid-19 Serology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Abbott Covid-19 Serology Testing Product Portfolio Table 39. Abbott Recent Development Table 40. Guangzhou Wondfo Biotech Company Information Table 41. Guangzhou Wondfo Biotech Business Overview Table 42. Guangzhou Wondfo Biotech Covid-19 Serology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Guangzhou Wondfo Biotech Covid-19 Serology Testing Product Portfolio Table 44. Guangzhou Wondfo Biotech Recent Development Table 45. BioMedomics Company Information Table 46. BioMedomics Business Overview Table 47. BioMedomics Covid-19 Serology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. BioMedomics Covid-19 Serology Testing Product Portfolio Table 49. BioMedomics Recent Development Table 50. Kantaro Company Information Table 51. Kantaro Business Overview Table 52. Kantaro Covid-19 Serology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Kantaro Covid-19 Serology Testing Product Portfolio Table 54. Kantaro Recent Development Table 55. Roche Company Information Table 56. Roche Business Overview Table 57. Roche Covid-19 Serology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Roche Covid-19 Serology Testing Product Portfolio Table 59. Roche Recent Development Table 60. Cellex Company Information Table 61. Cellex Business Overview Table 62. Cellex Covid-19 Serology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Cellex Covid-19 Serology Testing Product Portfolio Table 64. Cellex Recent Development Table 65. Innovita Biological Technology Company Information Table 66. Innovita Biological Technology Business Overview Table 67. Innovita Biological Technology Covid-19 Serology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Innovita Biological Technology Covid-19 Serology Testing Product Portfolio Table 69. Innovita Biological Technology Recent Development Table 70. Zhejiang Orient Gene Biotech Company Information Table 71. Zhejiang Orient Gene Biotech Business Overview Table 72. Zhejiang Orient Gene Biotech Covid-19 Serology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Zhejiang Orient Gene Biotech Covid-19 Serology Testing Product Portfolio Table 74. Zhejiang Orient Gene Biotech Recent Development Table 75. Ortho Clinical Diagnostics Company Information Table 76. Ortho Clinical Diagnostics Business Overview Table 77. Ortho Clinical Diagnostics Covid-19 Serology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Ortho Clinical Diagnostics Covid-19 Serology Testing Product Portfolio Table 79. Ortho Clinical Diagnostics Recent Development Table 80. Guangdong Hecin-Scientific Company Information Table 81. Guangdong Hecin-Scientific Business Overview Table 82. Guangdong Hecin-Scientific Covid-19 Serology Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Guangdong Hecin-Scientific Covid-19 Serology Testing Product Portfolio Table 84. Guangdong Hecin-Scientific Recent Development Table 85. Dynamiker Biotechnology (Tianjin) Company Information Table 86. Dynamiker Biotechnology (Tianjin) Business Overview Table 87. Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Product Portfolio Table 89. Dynamiker Biotechnology (Tianjin) Recent Development Table 90. Chembio Diagnostics Company Information Table 91. Chembio Diagnostics Business Overview Table 92. Chembio Diagnostics Covid-19 Serology Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Chembio Diagnostics Covid-19 Serology Testing Product Portfolio Table 94. Chembio Diagnostics Recent Development Table 95. Safecare Bio-Tech Company Information Table 96. Safecare Bio-Tech Business Overview Table 97. Safecare Bio-Tech Covid-19 Serology Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Safecare Bio-Tech Covid-19 Serology Testing Product Portfolio Table 99. Safecare Bio-Tech Recent Development Table 100. North America Covid-19 Serology Testing Revenue by Type (2021-2026) & (US$ Million) Table 101. North America Covid-19 Serology Testing Revenue by Type (2027-2032) & (US$ Million) Table 102. North America Covid-19 Serology Testing Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Covid-19 Serology Testing Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Covid-19 Serology Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Covid-19 Serology Testing Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Covid-19 Serology Testing Revenue by Country (US$ Million) & (2027-2032) Table 107. Europe Covid-19 Serology Testing Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Covid-19 Serology Testing Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Covid-19 Serology Testing Revenue by Application (2021-2026) & (US$ Million) Table 110. Europe Covid-19 Serology Testing Revenue by Application (2027-2032) & (US$ Million) Table 111. Europe Covid-19 Serology Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Covid-19 Serology Testing Revenue by Country (2021-2026) & (US$ Million) Table 113. Europe Covid-19 Serology Testing Revenue by Country (US$ Million) & (2027-2032) Table 114. China Covid-19 Serology Testing Revenue by Type (2021-2026) & (US$ Million) Table 115. China Covid-19 Serology Testing Revenue by Type (2027-2032) & (US$ Million) Table 116. China Covid-19 Serology Testing Revenue by Application (2021-2026) & (US$ Million) Table 117. China Covid-19 Serology Testing Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Covid-19 Serology Testing Revenue by Type (2021-2026) & (US$ Million) Table 119. Asia Covid-19 Serology Testing Revenue by Type (2027-2032) & (US$ Million) Table 120. Asia Covid-19 Serology Testing Revenue by Application (2021-2026) & (US$ Million) Table 121. Asia Covid-19 Serology Testing Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Covid-19 Serology Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Covid-19 Serology Testing Revenue by Region (US$ Million) & (2021-2026) Table 124. Asia Covid-19 Serology Testing Revenue by Region (US$ Million) & (2027-2032) Table 125. SAMEA Covid-19 Serology Testing Revenue by Type (2021-2026) & (US$ Million) Table 126. SAMEA Covid-19 Serology Testing Revenue by Type (2027-2032) & (US$ Million) Table 127. SAMEA Covid-19 Serology Testing Revenue by Application (2021-2026) & (US$ Million) Table 128. SAMEA Covid-19 Serology Testing Revenue by Application (2027-2032) & (US$ Million) Table 129. SAMEA Covid-19 Serology Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. SAMEA Covid-19 Serology Testing Revenue by Country (2021-2026) & (US$ Million) Table 131. SAMEA Covid-19 Serology Testing Revenue by Country (US$ Million) & (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Covid-19 Serology Testing Image Figure 2. Global Covid-19 Serology Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Covid-19 Serology Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Rapid Diagnostic Test (RDT) Image Figure 5. Chemiluminescent Immunoassay Image Figure 6. Other Image Figure 7. Global Covid-19 Serology Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Covid-19 Serology Testing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Third-party laboratory Image Figure 11. Global Covid-19 Serology Testing Market Size (US$ Million) & (2021-2032) Figure 12. Global Covid-19 Serology Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Covid-19 Serology Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Covid-19 Serology Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Covid-19 Serology Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Covid-19 Serology Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Covid-19 Serology Testing Revenue Market Share by Type (2021-2032) Figure 19. Global Covid-19 Serology Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Covid-19 Serology Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Covid-19 Serology Testing Revenue Market Share by Application (2021-2032) Figure 22. North America Covid-19 Serology Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Covid-19 Serology Testing Revenue Share by Type (2021-2032) Figure 24. North America Covid-19 Serology Testing Revenue Share by Application (2021-2032) Figure 25. North America Covid-19 Serology Testing Revenue Share by Country (2021-2032) Figure 26. United States Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Covid-19 Serology Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Covid-19 Serology Testing Revenue Share by Type (2021-2032) Figure 31. Europe Covid-19 Serology Testing Revenue Share by Application (2021-2032) Figure 32. Europe Covid-19 Serology Testing Revenue Share by Country (2021-2032) Figure 33. Germany Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Covid-19 Serology Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Covid-19 Serology Testing Revenue Share by Type (2021-2032) Figure 43. China Covid-19 Serology Testing Revenue Share by Application (2021-2032) Figure 44. Asia Covid-19 Serology Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Covid-19 Serology Testing Revenue Share by Type (2021-2032) Figure 46. Asia Covid-19 Serology Testing Revenue Share by Application (2021-2032) Figure 47. Asia Covid-19 Serology Testing Revenue Share by Region (2021-2032) Figure 48. Japan Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Covid-19 Serology Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Covid-19 Serology Testing Revenue Share by Type (2021-2032) Figure 56. SAMEA Covid-19 Serology Testing Revenue Share by Application (2021-2032) Figure 57. SAMEA Covid-19 Serology Testing Revenue Share by Country (2021-2032) Figure 58. Brazil Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Covid-19 Serology Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Rapid Diagnostic Test (RDT)
  • Chemiluminescent Immunoassay
  • Other
Applications
  • Hospitals
  • Third-party laboratory
Companies covered
  • Abbott
  • Guangzhou Wondfo Biotech
  • BioMedomics
  • Kantaro
  • Roche
  • Cellex
  • Innovita Biological Technology
  • Zhejiang Orient Gene Biotech
  • Ortho Clinical Diagnostics
  • Guangdong Hecin-Scientific
  • Dynamiker Biotechnology (Tianjin)
  • Chembio Diagnostics
  • Safecare Bio-Tech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Covid-19 Serology Testing Market by Type
  3. 1.2.1 Global Covid-19 Serology Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Rapid Diagnostic Test (RDT)
  5. 1.2.3 Chemiluminescent Immunoassay
  6. 1.2.4 Other
  7. 1.3 Covid-19 Serology Testing Market by Application
  8. 1.3.1 Global Covid-19 Serology Testing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Third-party laboratory
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Covid-19 Serology Testing Market Dynamics
  1. 2.1 Covid-19 Serology Testing Industry Trends
  2. 2.2 Covid-19 Serology Testing Industry Drivers
  3. 2.3 Covid-19 Serology Testing Industry Opportunities and Challenges
  4. 2.4 Covid-19 Serology Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Covid-19 Serology Testing Market Perspective (2021-2032)
  2. 3.2 Global Covid-19 Serology Testing Growth Trends by Region
  3. 3.2.1 Global Covid-19 Serology Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Covid-19 Serology Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Covid-19 Serology Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Covid-19 Serology Testing Revenue by Players
  2. 4.1.1 Global Covid-19 Serology Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Covid-19 Serology Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Covid-19 Serology Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Covid-19 Serology Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Covid-19 Serology Testing Key Players Headquarters & Area Served
  7. 4.4 Global Covid-19 Serology Testing Players, Product Type & Application
  8. 4.5 Global Covid-19 Serology Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Covid-19 Serology Testing Market CR5 and HHI
  11. 4.6.3 2025 Covid-19 Serology Testing Tier 1, Tier 2, and Tier 3
5 Covid-19 Serology Testing Market Size by Type
  1. 5.1 Global Covid-19 Serology Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Covid-19 Serology Testing Revenue by Type (2021-2032)
  3. 5.3 Global Covid-19 Serology Testing Revenue Market Share by Type (2021-2032)
6 Covid-19 Serology Testing Market Size by Application
  1. 6.1 Global Covid-19 Serology Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Covid-19 Serology Testing Revenue by Application (2021-2032)
  3. 6.3 Global Covid-19 Serology Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Covid-19 Serology Testing Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Guangzhou Wondfo Biotech
  8. 7.2.1 Guangzhou Wondfo Biotech Company Information
  9. 7.2.2 Guangzhou Wondfo Biotech Business Overview
  10. 7.2.3 Guangzhou Wondfo Biotech Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Guangzhou Wondfo Biotech Covid-19 Serology Testing Product Portfolio
  12. 7.2.5 Guangzhou Wondfo Biotech Recent Developments
  13. 7.3 BioMedomics
  14. 7.3.1 BioMedomics Company Information
  15. 7.3.2 BioMedomics Business Overview
  16. 7.3.3 BioMedomics Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BioMedomics Covid-19 Serology Testing Product Portfolio
  18. 7.3.5 BioMedomics Recent Developments
  19. 7.4 Kantaro
  20. 7.4.1 Kantaro Company Information
  21. 7.4.2 Kantaro Business Overview
  22. 7.4.3 Kantaro Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Kantaro Covid-19 Serology Testing Product Portfolio
  24. 7.4.5 Kantaro Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Roche Covid-19 Serology Testing Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 Cellex
  32. 7.6.1 Cellex Company Information
  33. 7.6.2 Cellex Business Overview
  34. 7.6.3 Cellex Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cellex Covid-19 Serology Testing Product Portfolio
  36. 7.6.5 Cellex Recent Developments
  37. 7.7 Innovita Biological Technology
  38. 7.7.1 Innovita Biological Technology Company Information
  39. 7.7.2 Innovita Biological Technology Business Overview
  40. 7.7.3 Innovita Biological Technology Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Innovita Biological Technology Covid-19 Serology Testing Product Portfolio
  42. 7.7.5 Innovita Biological Technology Recent Developments
  43. 7.8 Zhejiang Orient Gene Biotech
  44. 7.8.1 Zhejiang Orient Gene Biotech Company Information
  45. 7.8.2 Zhejiang Orient Gene Biotech Business Overview
  46. 7.8.3 Zhejiang Orient Gene Biotech Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Zhejiang Orient Gene Biotech Covid-19 Serology Testing Product Portfolio
  48. 7.8.5 Zhejiang Orient Gene Biotech Recent Developments
  49. 7.9 Ortho Clinical Diagnostics
  50. 7.9.1 Ortho Clinical Diagnostics Company Information
  51. 7.9.2 Ortho Clinical Diagnostics Business Overview
  52. 7.9.3 Ortho Clinical Diagnostics Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Ortho Clinical Diagnostics Covid-19 Serology Testing Product Portfolio
  54. 7.9.5 Ortho Clinical Diagnostics Recent Developments
  55. 7.10 Guangdong Hecin-Scientific
  56. 7.10.1 Guangdong Hecin-Scientific Company Information
  57. 7.10.2 Guangdong Hecin-Scientific Business Overview
  58. 7.10.3 Guangdong Hecin-Scientific Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Guangdong Hecin-Scientific Covid-19 Serology Testing Product Portfolio
  60. 7.10.5 Guangdong Hecin-Scientific Recent Developments
  61. 7.11 Dynamiker Biotechnology (Tianjin)
  62. 7.11.1 Dynamiker Biotechnology (Tianjin) Company Information
  63. 7.11.2 Dynamiker Biotechnology (Tianjin) Business Overview
  64. 7.11.3 Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Product Portfolio
  66. 7.11.5 Dynamiker Biotechnology (Tianjin) Recent Developments
  67. 7.12 Chembio Diagnostics
  68. 7.12.1 Chembio Diagnostics Company Information
  69. 7.12.2 Chembio Diagnostics Business Overview
  70. 7.12.3 Chembio Diagnostics Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Chembio Diagnostics Covid-19 Serology Testing Product Portfolio
  72. 7.12.5 Chembio Diagnostics Recent Developments
  73. 7.13 Safecare Bio-Tech
  74. 7.13.1 Safecare Bio-Tech Company Information
  75. 7.13.2 Safecare Bio-Tech Business Overview
  76. 7.13.3 Safecare Bio-Tech Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Safecare Bio-Tech Covid-19 Serology Testing Product Portfolio
  78. 7.13.5 Safecare Bio-Tech Recent Developments
8 North America
  1. 8.1 North America Covid-19 Serology Testing Revenue (2021-2032)
  2. 8.2 North America Covid-19 Serology Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Covid-19 Serology Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Covid-19 Serology Testing Revenue by Type (2027-2032)
  5. 8.3 North America Covid-19 Serology Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Covid-19 Serology Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Covid-19 Serology Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Covid-19 Serology Testing Revenue by Application (2027-2032)
  9. 8.5 North America Covid-19 Serology Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Covid-19 Serology Testing Revenue by Country
  11. 8.6.1 North America Covid-19 Serology Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Covid-19 Serology Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Covid-19 Serology Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Covid-19 Serology Testing Revenue (2021-2032)
  2. 9.2 Europe Covid-19 Serology Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Covid-19 Serology Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Covid-19 Serology Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Covid-19 Serology Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Covid-19 Serology Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Covid-19 Serology Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Covid-19 Serology Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Covid-19 Serology Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Covid-19 Serology Testing Revenue by Country
  11. 9.6.1 Europe Covid-19 Serology Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Covid-19 Serology Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Covid-19 Serology Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Covid-19 Serology Testing Revenue (2021-2032)
  2. 10.2 China Covid-19 Serology Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Covid-19 Serology Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Covid-19 Serology Testing Revenue by Type (2027-2032)
  5. 10.3 China Covid-19 Serology Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Covid-19 Serology Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Covid-19 Serology Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Covid-19 Serology Testing Revenue by Application (2027-2032)
  9. 10.5 China Covid-19 Serology Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Covid-19 Serology Testing Revenue (2021-2032)
  2. 11.2 Asia Covid-19 Serology Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Covid-19 Serology Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Covid-19 Serology Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Covid-19 Serology Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Covid-19 Serology Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Covid-19 Serology Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Covid-19 Serology Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Covid-19 Serology Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Covid-19 Serology Testing Revenue by Country
  11. 11.6.1 Asia Covid-19 Serology Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Covid-19 Serology Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Covid-19 Serology Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Covid-19 Serology Testing Revenue (2021-2032)
  2. 12.2 SAMEA Covid-19 Serology Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Covid-19 Serology Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Covid-19 Serology Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Covid-19 Serology Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Covid-19 Serology Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Covid-19 Serology Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Covid-19 Serology Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Covid-19 Serology Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Covid-19 Serology Testing Revenue by Country
  11. 12.6.1 SAMEA Covid-19 Serology Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Covid-19 Serology Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Covid-19 Serology Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst